TAMARA GRAHAM: Open Payments
NPI 1114173846 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 16 payments from 8 companies in 2025. Trend: 2023 $543 · 2024 $604 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| PFIZER INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $45 |
| Dexcom, Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| SHIELD THERAPEUTICS INC | 1 | $33 |
| ABBVIE INC. | 1 | $15 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, LEQVIO, ACCRUFER, PAXLOVID, Rybelsus, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
